Your session is about to expire
← Back to Search
Procedure
Inter-fascial Plane Between the SArtorius Muscle and FEmoral Artery (ISAFE) (ISAFE Trial)
N/A
Waitlist Available
Research Sponsored by University of Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 and 48 hours
Awards & highlights
No Placebo-Only Group
Summary
This trial tests a new method for placing a pain relief tube in patients undergoing knee replacement surgery. The new method aims to provide better and longer-lasting pain relief by positioning the tube between a thigh muscle and an artery. This placement helps keep the tube in place and avoids complications.
Eligible Conditions
- Conduction Anesthesia
- Knee Replacement Surgery
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 24 and 48 hours
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 and 48 hours
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Catheter dislodgement
Secondary study objectives
Incidence of catheter insertion related complications
Incidence of sensory block
Number of attempts for catheter insertion
+4 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: ISAFE techniqueExperimental Treatment1 Intervention
Adductor canal block catheter tip located in the fascial plane between sartorious muscle and femoral artery.
Group II: Conventional techniqueActive Control1 Intervention
Adductor canal block catheter tip located in lateral to the femoral artery.
Find a Location
Who is running the clinical trial?
University of TorontoLead Sponsor
725 Previous Clinical Trials
1,115,596 Total Patients Enrolled
Mount Sinai Hospital, CanadaOTHER
204 Previous Clinical Trials
69,097 Total Patients Enrolled
Yehoshua Gleicher, MD, MScStudy ChairUniversity of Toronto